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Abstract
Background: Urinary incontinence (UI) affects up to 40% of adult women within the UK, and pelvic floor muscle
training can be effective as a treatment. The prevalence of UI is higher in athletic women than in their sedentary
counterparts, but there is little research into reasons for this or into treatment within this population.
The aim of this study is to investigate the feasibility of conducting a future randomised controlled trial of
physiotherapeutic management of UI in athletic women.
Methods: This is a mixed methods study with three distinct but related phases.
Phase 1: Semi-structured interviews with health care professionals in the community will explore current
management practices of UI in women and particularly in female athletes in order to inform the control arm of a
future study. It will also establish community health care professionals’ understanding of pelvic health
physiotherapy.
Phase 2: Athletic and regularly exercising women recruited directly from gyms and sports clubs will undergo a
course of physiotherapy to manage UI. This will establish study recruitment, eligibility, consent, attendance, attrition,
and data completion rates. It will provide information regarding appropriate clinical venues and outcome measures
to use for this patient group.
Phase 3: Semi-structured interviews with purposefully selected participants from phase 2 will investigate participant
satisfaction with recruitment procedures, the intervention, outcome measures and the venues. Further, we will
collect data regarding the use of a smartphone ‘app’ for adherence and monitoring of home exercises and
participants’ beliefs around randomisation in a future study. We will explore the impact of UI on life and sport in
more detail.
Discussion: This study will establish the ease and acceptability of recruiting athletic women directly from gyms and
sports clubs and identify attrition rates. It will also explore the acceptability of the intervention, clinical venues and
outcome measures. Data collected will be used to inform a future randomised controlled trial.
Trial registration: NCT03986411 (clinicaltrials.gov). Registered on 14 June 2019
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Background
Urinary incontinence (UI) is a common problem, with
prevalence reported to be as high as 40% of adult
women in the UK [1]. UI is defined as involuntary loss
of urine [2]. The term includes stress urinary incontin-
ence (SUI) associated with physical exertion, such as
sports, or coughing and sneezing, and urgency urinary
incontinence (UUI), which is leaking associated with in-
creased urgency or desire to void. Women may experi-
ence a combination of these symptoms, that is, mixed
urinary incontinence (MUI) [2]. UI is embarrassing and
debilitating, affecting all aspects of life. There is evidence
that it reduces participation in sport and exercise [3, 4],
affects employment, causes absence from the workplace
[5], and is detrimental to personal relationships [6]. It is
widely accepted that UI can be associated with child-
birth, obesity and the ageing process [7]. The primary
cause is presumed to be weakness of the pelvic floor
muscles (PFM), and the optimal first line in treatment is
therefore to improve PFM function with exercises to im-
prove strength, timing and endurance [8, 9]. Evidence
supports a supervised pelvic floor muscle training
(PFMT) programme for 3 months in the general popula-
tion [10]. This is recommended in the recent guidelines
as first line management of UI by the National Institute
for Health Care and Excellence (NICE) [11].
Somewhat surprisingly, the prevalence of UI in young,
nulliparous athletes with apparently low risk reveals par-
ticularly high rates, ranging from 23–41% [12–15]. UI in
athletic women has been reported to be almost double
that in a matched group of sedentary individuals [16].
Indeed, an investigation into recreationally active women
revealed an even higher occurrence of 49% [17]. This
population had a large age range, 18–83, and parity,
which may explain the high prevalence in comparison to
other studies of younger nulliparous women with fewer
risk factors.
There is robust evidence to support pelvic floor
muscle training as a treatment intervention in women
with UI [18]. In a recent Cochrane review, which in-
cluded 31 studies and 1837 women from 4 countries, the
authors concluded that, in the short term at least, PFMT
could effect a cure or improvement in the symptoms of
all types of UI [9]. However, studies generally did not
follow up treatment effects for more than 1 year, and it
was noted that there was a greater improvement rate in
those with SUI than other types of UI. Despite the high
prevalence of UI in athletic women, there is, however,
little research regarding the management of UI within
this group [19–21].
It has been suggested that there are two conflicting
mechanisms for UI in athletic women: firstly, that ath-
letes have stronger pelvic floors than non-athletes due to
the training effect of repeated impact, and secondly, that
the repeated challenge of ground reaction forces from
running and jumping may instead weaken and stretch
the fascia and muscle tissues within the pelvis [22]. In a
recent study, comparing continent and incontinent ath-
letes, those that were incontinent were found to have
stronger pelvic floor muscles [23].
It is possible that if the pelvic floor muscle is strong
and stiff but inextensible, or unable to relax fully, this
will cause urinary symptoms. An overactive group of
PFM would potentially be unable to react to ground re-
action forces adequately, as it is already in a shortened
position [24].This may explain why athletes with strong
pelvic floors would still present with UI. Increased PFM
tension has been noted in cases of increased urinary ur-
gency and frequency with or without associated pelvic
pain [25]. Indeed, assessment of some PFM can reveal
areas within the tissue that are overactive or ‘tight’ [26]
although there is little published data regarding how
prevalent this is or whether it is more likely in certain
groups of women. It is, however, reasonable to suggest
that the PFM in a symptomatic athlete will be dysfunc-
tional as opposed to weak. In this case, it is imperative
that the muscles undergo specialist assessment in order
to identify the appropriate training and rehabilitation
programme for the individual. Standard, prescriptive
protocols via leaflets, advising general PFM strengthen-
ing without tailored advice, may not afford any real im-
provement and indeed, could aggravate the symptoms.
Despite the high prevalence of UI in women, fewer
than half will present to healthcare professionals for help
[1]. This is potentially an even bigger issue in athletes
with UI, where 90% of those reporting UI in question-
naires had not previously mentioned their symptoms to
anyone [14]. It is important to understand why these
women do not seek help and ensure that those that do
so are offered effective, evidence-based treatment.
It has been identified that there is a need for high-
quality research in this area and specifically randomised
clinical trials [21]. Our ultimate aim is to conduct a ran-
domised controlled trial (RCT) to determine whether
one to one physiotherapy is an acceptable, cost-effective
way to improve the symptoms of UI in athletic women.
This study is a first step to investigating the feasibility
of conducting such a trial. It will explore treatments
currently offered within the community setting to
athletic women presenting with UI. Further, it will in-
vestigate the acceptability of direct recruitment from
gyms and sports clubs and of providing one to one
specialist pelvic physiotherapy within this cohort. It
will provide information about the consent proce-
dures, outcome measures and retention of partici-
pants. This feasibility study will enable us to
determine whether conducting a definitive appropri-
ately powered trial is possible.
Campbell et al. Pilot and Feasibility Studies           (2020) 6:103 Page 2 of 11
Methods
Study Management
A steering group comprised of the co-investigators, two
service representatives and a specialist pelvic health
physiotherapist will guide the overall management of the
study.
Study Objectives
Phase 1
1. To identify the current knowledge base of health
care professionals within the community setting,
regarding the management of UI in women
2. To identify treatment strategies and referral
pathways available to women with UI in the
community setting
3. To explore any variation in the management of
athletic women with UI compared to that for all
women
Phase 2
To determine the following:
1. Recruitment rate: the ease with which athletic
women with UI may be recruited directly from
sports clubs and gyms
2. Eligibility rate: the proportion of volunteers
screened that are eligible for inclusion
3. Consent rate: the proportion of those eligible
women that consent both for the trial and,
separately, for intimate examination of their pelvic
floor muscles
4. Attendance rate: the proportion of participants who
attend over 50% of planned sessions
5. Data completion rate: the number of questionnaires
returned at the 3-month and 6-month time points
Phase 3
To establish:
1. Acceptability of the recruitment process
2. Acceptability of the intervention to participants
3. Outcome measures: to identify the acceptability of
the outcome measures to participants for use in a
future study
4. Choice of venue: acceptability of venue to the
participants
5. Ease of use and perceived benefit of using a
smartphone ‘app’ to aid PFMT adherence and
recording
6. Acceptability to participants of being randomised
for treatment in a future trial
A traffic light system (based on that used in a protocol
by Pitt et al. 2020) [27] will be used to review progres-
sion criteria to a full trial. Green will indicate that it is
feasible to progress to a definitive trial with only minor
or no changes made to the study design and procedures,
amber will indicate that modifications should be made
before progressing and red will indicate that it is not
feasible to progress with this design (see Table 1).
The steering group will oversee the final decision on
whether to progress to a definitive study dependent on
the results.
Study Design
This is a mixed methods study with three distinct but
related phases.
Phase 1
Aim To identify current first-line treatment provision
within the community for UI in women and specifically
athletic women. This is to establish current practice in
order to inform the control arm of a future trial.
Participants We will recruit six to eight local health
care professionals (HCP) from the Derbyshire and Notting-
hamshire areas for interview. This has been dictated largely
by the time and resources available but will also provide a
snapshot of the key issues to be addressed in future re-
search. The HCP will be comprised of GPs, nurses, and
physiotherapists as these are likely to be the point of first
contact for women with UI in the community. We will aim
to recruit the same numbers from all three professions.
The aim is to recruit professionals that woman seek help
from in the first instance, rather than to specifically recruit
those with a particular specialisation in pelvic or women’s
health. All participants will be required to provide full, in-
formed, written consent before any data is collected.
Interviews These semi-structured interviews will ex-
plore the current general understanding of what consti-
tutes appropriate management of UI in the community.
It will establish whether participants are aware of NICE
guidelines or if there is any local pathway for the man-
agement of UI or a specific referral process. Further, it
will explore if the HCP would feel confident to provide
structured rehabilitation for the PFM and whether they
would supervise this or whether they would seek referral
to a specialist physiotherapist or a continence advisor.
We will ascertain whether they would manage athletic
or sporting women in the same way as other women
with UI and if they feel that women with UI should be
encouraged to continue with their sport despite the in-
continence. Participants will be asked to discuss their
understanding of specialist pelvic health physiotherapy,
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what it entails and if they know where and/or how they
could refer to such a service. These interviews will be
conducted by a specialist pelvic health physiotherapist
with an understanding of the pathways and local ser-
vices. Where interviewees do not raise particular points,
for example, knowledge of the appropriate NICE guide-
lines, they will be prompted about this using a pre-
prepared interview schedule.
Setting Interviews will take place at a time and in a
place that is acceptable to the participants and are
planned to last for up to 30 min.
Phase 2
Aims To investigate the feasibility of recruitment and
retention of athletic and/or sporting women who self-
Table 1 Table to illustrate criteria for progression from feasibility study to a definitive trial
Progression criteria Measurement Green Amber Red
Phase 2
Recruitment Number of participants
recruited within 6 months
15–20 10–15 < 10
Eligibility Proportion of those
screened that are eligible
> 75% screened are eligible Minor changes to
eligibility criteria
would increase the
number to > 75%
Majority of those screened
are ineligible or changes to
inclusion criteria required
would prohibit meaningful
results
Initial consent Proportion of eligible
participants who consent
> 70% 50–69% < 50%
Consent to intimate
examination
Proportion of those enrolled
who consent to intimate
examination of PFM
> 70% 50–69 % < 50%
Attendance Number of scheduled
appointments attended
by participants
> 75% 50–75% < 50%
Data completion Follow-up questionnaire
collected at 3-month review
> 75% 50–75% < 50%
Follow-up questionnaires
collected at 6-month review
> 60% 30–60% <30%
Phase 3
Recruitment process Qualitative process
evaluation
Most participants find the
recruitment process
acceptable or minor
changes requested
Participants views
on acceptability
conflicting or larger
changes required
Most participants find the
recruitment process
unacceptable or the changes
required are unrealistic
Acceptability of
intervention
Qualitative process
evaluation
Most participants find the
intervention acceptable or
would request only minor
alterations
Views on acceptability
conflicting or major
revisions needed
Most participants find the
intervention unacceptable
or changes required are
not feasible
Acceptability of outcome
measures
Qualitative process
evaluation
Most participants find the
questionnaires acceptable
or would request only
minor alterations
Views on acceptability
conflicting or major
revisions needed
Most participants find the
questionnaires unacceptable
or changes required are not
feasible
Choice of venue Qualitative process
evaluation
Most participants find the
venue acceptable or would
request only minor alterations
Views on acceptability
conflicting or major
revisions needed
Most participants find the
venue unacceptable or
changes required are not
feasible
Use of Squeezy App Qualitative process
evaluation
Most participants find use
of a smartphone app easy
and beneficial as a reminder
for PFMT
Fewer than half find
use of a smartphone
app beneficial
Most participants find use of a
smartphone app not helpful or
easy to use
Acceptability of being
randomised in a future trial
Qualitative process
evaluation
Most participants would
accept being randomised for
interventions in a future trial
Most would accept
being randomised for
interventions if there
was an option to
receive the intervention
post RCT
Most participants would not
accept being part of a control
group in an RCT
This table has been adapted from Pitt et al. 2020 [27]
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report the symptoms of SUI, UUI, MUI and/or increased
urinary urgency and/or frequency, from the community
for a trial of physiotherapeutic management of UI. Fur-
ther, to explore the proportion of those screened who
are eligible and then consent to the process and to an in-
timate examination. To record the attendance rates and
data completion at 3 and 6months
Consent All participants will be required to provide full,
informed, written consent before any data is collected
and the intervention begins. In addition, participants in
phase 2 will receive further information regarding having
a digital vaginal examination (DVE) of their pelvic floor
muscles. In line with Chartered Society of Physiotherapy
(CSP) guidelines, the option of a chaperone will be of-
fered for this procedure should participants wish [28].
Further informed written consent will be required prior
to the DVE. If any participant does not wish to proceed
at this stage, they will be given a leaflet and general ad-
vice and will be offered the opportunity to continue with
the questionnaires at 3 months and at 6 months. This
will provide an indication of potential attrition of partici-
pants not wishing to receive specialised physiotherapy,
for a future trial.
Participants We will recruit 15–20 sporting and/or ath-
letic women from local sports clubs and gyms who self-
report symptoms of UI.
All participants must be female athletes or regular ex-
ercisers, 18 years of age and over, who self-report symp-
toms of UI.
UI will be defined as leaking of urine associated with in-
creased abdominal pressure such as impact, coughing
and/or sneezing, leaking associated with urinary urgency
and will include increased urinary urgency and/or urinary
frequency such that it is bothersome to the woman [2].
Athletic or sporting women will be defined as adult
women exercising (moderate to vigorous) or participat-
ing in sport three or more times a week and for more
than 150 min (i.e. meeting or exceeding The UK Chief
Medical Officers’ Physical Activity Guidelines [29]).
Participants will not be eligible if they are new to sport
within the last year, are pregnant or less than 1 year
post-natal, or have commenced oestrogen or anticholin-
ergic treatment within the previous 3 months. They will
be ineligible if they are involved in ongoing physiother-
apy/continence advice treatment elsewhere within the
previous year or have an existing neurological condition
that may contribute to UI. Participants that are unable
to read or understand English will be ineligible for the
study as the study documents are in English.
Recruitment We will target gyms and sports clubs in
the local community via social media, email and flyers to
identify potentially interested members. Managers of the
gyms and secretaries of the sports clubs will be offered
the opportunity to host informative talks by the re-
searcher (KGC) regarding pelvic health issues in women
and provision of further information regarding the
study.
Interested participants who make contact by email or
by telephone will be sent participant information sheets.
They will be directed to reply by email acknowledging
their interest in proceeding within the study and provid-
ing a telephone number and time for the researcher to
contact them: this will be taken as consent for that tele-
phone number to be used for this purpose. Within the
follow-up telephone call, any further questions the par-
ticipant may have will be answered, they will be screened
for eligibility, and an appointment will be booked for
those that wish to take part.
Intervention At the initial appointment, the study regi-
men and questionnaires will be explained in more detail.
In addition, participants will be informed how to
complete the logs to record their weekly sporting activ-
ities and fluid charts that will be required as part of the
trial. Further, they will be issued with two jugs to enable
accurate measurement of input and output of fluid/urine
and a pot to collect a mid-stream urine sample (MSU),
in order to check for any signs of urinary tract infection,
as recommended in the NICE guidelines [11]. Clinically
we have found that patients have often misunderstood
how to complete 3-day fluid charts correctly if these are
not explained face-to-face. This meeting will also allow
time for a full explanation of the assessment and treat-
ment process, including the digital vaginal examination
of their pelvic floor muscles, and whether they might
wish to have a chaperone for this procedure. It is good
practice ( Chartered Society of Physiotherapy) to ensure
that all patients are given full information regarding any
intimate examination prior to this appointment [28].
Face-to-face contact allows for explanations and time for
the participant to consider fully whether they wish to
proceed. Written informed consent will be taken prior
to any data collection. A second appointment will then
be made where baseline questionnaires, the fluid chart,
the MSU and sporting log will be collected. There will
be a subjective assessment to explore medical and demo-
graphic history and an objective assessment which will
include visual inspection and digital palpation of the
perineum, vagina and PFM. This is to establish baseline
levels of PFM resting tone, power and endurance in
crook lying. It is planned to use electromyography
(EMG) to monitor resting tone, power and endurance in
standing. This will be dependent on the individual par-
ticipant’s agreement.
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Results of the assessments will be recorded and dis-
cussed with the participant. A treatment plan, derived
from the assessment findings, will be discussed and
agreed before proceeding.
The intervention will be tailored to the individual but
will involve the core components of pelvic floor muscle
training (PFMT). This will have two aspects, a home
programme and supervised work within the clinic to en-
sure correct technique and appropriate progression.
PFMT is defined as ‘exercise to improve PFM strength,
endurance, power, relaxation or a combination of these
parameters’ [30]. In addition, in some cases, the inter-
vention may include soft tissue techniques to release
tight muscles where required to comply with the PFMT.
Participants will be taught correct PFM contraction
and relaxation, which will be confirmed by digital vagi-
nal examination (DVE) in crook lying. This can be con-
solidated in standing using EMG biofeedback. As part of
the progression, women will be encouraged to practice
exercises in different, functional positions. They will be
taught to recruit the PFM pre-emptively, to brace before
impact (e.g. coughing and sneezing), which is a tech-
nique referred to as ‘the knack’ [31].
Participants will be offered access to the ‘Squeezy
App’, which is a smartphone app that enables the par-
ticipant to set reminders for their PFMT. This can be
customised for each individual. The ‘Squeezy App’ is
connected to an online platform ‘Living With’ where the
practitioner can view exercise adherence, as long as the
participant uses the app for each set of exercises
throughout the day and saves a record to their phone.
Those that do not wish to use this app will be provided
with a paper log in order that they can record each exer-
cise set within the day, manually.
It is planned that participants will attend for no more
than seven appointments, including the initial appoint-
ment for explanation and consent, with a specialist pel-
vic health physiotherapist over a 6-month period. This is
in keeping with practice nationally: A recent survey of
specialist pelvic health physiotherapists showed that the
number of one to one exercise sessions offered was 4.4
± 1.3 within the NHS [32]. Each appointment will be
planned to take 45–60min, although this may reduce to
30–45min after the initial assessments are complete.
The regularity and number of appointments will depend
on the participant’s needs and necessary progression in
the programme. Each participant’s individual interven-
tion will be recorded, and information from this will in-
form future interventions offered as part of a future trial.
Setting Participants will be offered a choice of venue be-
tween a community physiotherapy clinic and a private
room within the University of Nottingham. Offering a
choice of venues will enable us to assess the venues for a
future trial in order to optimise participant retention.
Outcome measures As this is a feasibility study, a range
of outcome measures will be explored. This will be with
a view to defining acceptability for the participants
whilst still achieving the optimum data required for the
analysis. With this in mind, two questionnaires will be
used for participants in phase 2 alongside measures of
pelvic floor strength and a record of urinary symptoms:
 The short urinary distress inventory UDI-6: This is a
brief measure of how bothersome the symptoms of
UI are to the individual. It is easy and quick to
complete and is a reliable outcome measure [33].
 The International Consultation on Incontinence
Modular Questionnaire Female Lower Urinary Tract
Symptoms Long Form Module (ICIQ-FLUTS-lf)
[34]: Although this is a long questionnaire, the
decision to include this was due to the
comprehensive amount of information it reveals. It
reports not just the severity and impact of any UI
symptoms but also the information about the nature
of the urinary symptoms experienced and the effects
of these on quality of life. The ICIQ modules are
widely used as an outcome measure both in pelvic
health research and in clinical practice and have
been validated as reliable measures [35].
 A 3-day fluid chart: This will record, throughout,
volumes and types of fluid drunk, volumes and fre-
quency of urinary voids and any leaks experienced.
 The objective examination will include a DVE of the
participant’s pelvic floor. The resting ‘tone’ of the
muscles will be noted within the participant’s notes on
a chart of the superficial and deep pelvic floor muscle
fibres as low, moderate, or high. Maximum voluntary
contraction will be recorded using the modified Oxford
scale for the average score over three, 3 s holds with
10 s rest. The amount of PFM movement will also be
noted with the contraction, to ensure an upward and
inward lift of the perineum [36].
 EMG (electromyogram), as a secondary outcome
measure: Where acceptable to the participant a
vaginal surface EMG probe, PeriformR +,
neenpelvichealth.com, will be used to collect data on
PFM activity in standing via a Neurotrac Myoplus
Pro, https://veritymedical.co.uk/, as commonly used
in clinical practice. Measurements will be taken at
rest, in standing, to record levels of resting tone and
maximum voluntary contraction (MVC). MVC will
be the average of three, 3 s maximal holds with 10 s
rest. Resting tone will again be noted after maximal
efforts to ensure full relaxation post contraction.
Although some recent reviews, e.g. Nunes et al.
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2019 have suggested that EMG biofeedback offers
no real benefit for the treatment of UI over other
treatment interventions and PFMT, this could be
due to the lack of homogeneity of the studies
included. Moreover, EMG provides a valuable
addition in terms of motivation for patients who use
this tool [37].
The DVE and EMG measurements will be taken after
requesting additional consent from the participant.
Each outcome, including the objective assessments,
will be assessed and recorded at baseline, at 3 months
and at 6 months after recruitment. It is planned to col-
lect the outcome measures at scheduled appointments.
The fluid charts, sporting logs, UDI 6 and ICIQ-FLUTS-
lf will be in the form of paper questionnaires. The data
from UDI 6 and ICIQ-FLUTS-lf will not be analysed
until the study is concluded. Should participants not be
able or willing to attend, an email will be sent requesting
completion of the questionnaires. A stamped-addressed
envelope will be provided for return. See Fig. 1 for de-
tails of flow of participants in the study.
Phase 3
Aim To investigate the acceptability to participants of
the recruitment process, the intervention, the outcome
measures and the venue. It will collect data regarding
participants’ experiences of using the smartphone app
and their thoughts regarding randomisation in a future
study. We will also explore previous treatments for UI
that participants may have accessed and the effects of UI
on their quality of life and on their sporting activity
specifically.
Participants Six to eight participants from phase 2 will
be recruited for an in-depth interview. This will be a
purposeful selection to ensure a range of ages, types
of incontinence and sporting backgrounds. Partici-
pants will be required to provide additional informed,
written consent before any data is collected for this
phase. This is again in keeping with the time and re-
sources available to us.
Interviews Semi-structured interviews will explore the
acceptability of the recruitment process, the outcome
measures, the setting and the intervention. It is also
planned that the interviews will gain further insight into
the impact of UI on the participants’ quality of life and
their sporting aspirations. The interviews in this phase
will be conducted by an experienced qualitative re-
searcher who has not been previously involved in phase
1 or 2. We will refer to the theoretical framework of ac-
ceptability when devising the interview schedule in phase
3 in order that the data provides richer information re-
garding the intervention and acceptability of the study
design [38].
Setting Interviews will be conducted at a time and place
convenient to the participant and are expected to take
approximately 30 min.
Sample size and justification
In phases 1 and 3, we plan to recruit six to eight partici-
pants. This reflects the time and resources available for
these phases of the study. This sample size has been de-
termined as being of sufficient size to address the re-
search aims within the time frame and funding available
[39].
In phase 2, we will recruit 15–20 athletic or sporting
women. As this is a feasibility study, the purpose is to
obtain estimates of recruitment and retention rates
alongside the acceptability of the intervention. There-
fore, a formal sample size calculation is not required.
Traditionally, sample sizes of between 24 and 50 are rec-
ommended for a feasibility study, but the intensity and
length of the proposed intervention also needs to be
considered [40]. We believe that this sample size is suffi-
cient to identify attrition, eligibility, consent, attendance
and data completion rates, within the time frame avail-
able to the study.
Analysis
In phases 1 and 3, digital audio-recordings of the inter-
views will be transferred to a secure and password-
protected file on a dedicated web server at the University
of Nottingham. Personal identifiers will be removed. The
recording will then be deleted from the recording device.
Anonymised recordings will be sent electronically to a
transcribing service approved by the University of Not-
tingham and then uploaded into the qualitative software
package NVivo 12 for line by line coding. Qualitative
data from these recordings will be analysed using a
framework approach [41], which is a pragmatic method
of organising, analysing and interpreting data around
focal research questions. Anonymised interview data will
be read and re-read several times, to explore data for
themes before coding begins. Three researchers will each
review a sample of the transcriptions in order to identify
themes across the datasets. A working analytical frame-
work will be developed, and data chunks will be trans-
ferred onto a framework matrix. Thematic table
summaries will be used to generate recommendations
about the nature of the subsequent trial; specific detail
will also be used to inform recruitment strategies, data
collection regimes and participant information
resources.
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In phase 2, numbers and characteristics of participants
will be summarised using descriptive statistics, and com-
pleteness of data will be assessed. Descriptive sum-
maries of outcome data at each follow-up time point
will be presented. The Template for Intervention, De-
scription and Replication (TIDieR) guidelines will be
used to describe the details of the intervention to en-
sure that it is reported in sufficient detail for replica-
tion [42]. As previously described, a traffic light
system will be used to identify whether each outcome
has met the requirements for progression of this
study to a definitive trial.
Participant Withdrawal
In each of the study phases, participants may withdraw
from the study either at their own request or be with-
drawn at the discretion of the Investigator. Participants
will be made aware (via the participant information
sheet and consent form) that should they withdraw, the
YES
Recruitment from sports clubs and gyms
Explanation of questionnaires and process
Informed consent to enter study Excluded
E
N
R
O
L
M
E
N
T
Home exercises and clinic support and training 
where required
Objective assessment and intervention plan
Baseline questionnaires returned, subjective assessment 
Informed consent for digital vaginal examination
Exercise sheet given
3 month follow up: Questionnaires returned and assessment
Home exercises and clinic support and 
training where required
6 month follow up: Questionnaires returned and assessment
IN
T
E
R
V
E
N
T
IO
N
F
O
L
L
O
W
 U
P
End of Study
YES
NO
NO
Fig. 1 Flow chart of participants’ progress through phase 2
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data collected cannot be erased and may still be used in
the final analysis.
Participants who withdraw will be replaced if this is
possible within the time frame of the study.
Data management
Each participant will be assigned a study identity code
number, for use on study forms, other study documents
and the electronic database. Study forms shall be re-
stricted to those personnel approved by the Chief Inves-
tigator and recorded as such in the study records.
Medical records will be stored securely and in accord-
ance with good clinical practice for a time period of 8
years from the last intervention. This is the recom-
mended time for record retention by the Chartered Soci-
ety of Physiotherapy who will be providing professional
liability. Computer-held data including the study data-
base will be held securely and password protected. All
data will be stored on a secure dedicated web server.
Adverse events
The occurrence of an adverse event as a result of partici-
pation within this study is not expected in phases 1 or 3.
Any adverse event data will be collected and reported.
It is again unlikely that any adverse events are likely to
arise as part of the intervention in phase 2, as the inter-
vention is standard physiotherapy practice for this issue,
but any observation of unexpected pathology or trauma,
e.g. cancer, female genital mutilation or history of abuse
during the subjective or objective parts of the assessment
process, will be discussed with the gynaecologist advising
the research team, and appropriate advice taken.
Discussion
UI is a debilitating condition that affects up to 40% of all
UK women [1] and up to a third of young nulliparous
female athletes [16]. Despite this, there is little evidence
regarding the effects of treatment in this population and
there is need for high-quality RCTs to investigate the
benefits and cost effectiveness of PFMT to treat PFM
disorders in athletes [21]. This article provides the meth-
odology for an initial study investigating the feasibility of
conducting a future RCT of physiotherapy management
of urinary incontinence in athletic women.
We anticipate several potential challenges within the
study:
1. As we have no means of knowing the number of
potential participants our flyers will reach, we are
unable to estimate the denominator for
recruitment. We can, however, collate potential
issues with recruitment in this environment, such
as the ease of distribution within clubs and gyms,
and explore ways to potentially maximise
distribution.
2. The subject of UI is a sensitive area and it may be
that potential participants are reluctant to present
due to embarrassment or that they may not wish to
share fully their experiences with us in phase 3.
3. We plan to use a smartphone app to help illustrate
compliance. Whilst feedback from users and
clinicians has shown that this improves compliance
and outcomes, we do not know whether it is
effective at illustrating compliance as it will still rely
on the user documenting the incidence of their
exercises effectively.
4. The acceptability of the intervention will be
assessed post intervention, and some have argued
that this may not reflect whether a healthcare
intervention is truly acceptable [43]. However, by
giving a full explanation by telephone and then
again in person before embarking on the full
assessment, we will allow volunteers to select this
intervention as acceptable or not at this point.
By employing a mixed methodology, we will be able to
obtain information on current knowledge and services
from a number of sources. Further, it will maximise the
collection of important data in order to inform a poten-
tial future trial.
Trial status
The trial was registered on clinicaltrials.gov (NCT03986411)
on 14 June 2019. Recruitment of participants was initiated
on 17 September 2019 and will conclude on 31
March 2020. We have currently recruited and inter-
viewed seven of eight possible participants in phase 1
and 10 of 20 potential participants in phase 2.
Dissemination and outputs
The study results will be shared via publication in peer-
reviewed academic journals, will be disseminated at con-
ferences and will be deposited in the University of Not-
tingham, Research Information Service Repository for
access.
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